Ozempic, Wegovy list prices to be slashed by up to 50%

Weight loss drugmaker Novo Nordisk will cut the list prices of Ozempic and Wegovy by up to 50% beginning in 2027, the company announced this week.

Wegovy currently carries a list price of $1,349 per month, while Ozempic is listed at $1,028 for a one-month supply. Both drugs will be listed at $675 per month beginning on Jan. 1, 2027, “representing reductions of approximately 50% and 35% for Wegovy and Ozempic, respectively,” according to Novo Nordisk.

The price cut will be designed to make Ozempic and Wegovy more affordable for people who receive the diabetes an...